RUNX2 and neoplasm: Indeed, reduced in vitro infection and viral spread, as well as delayed tumor activation in a MYC/Runx2 mouse model using replication-competent recombinant MuLV lacking a functional (i.e., BET protein-binding) ET domain-binding motif, have been reported [50].